Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2014 08:31 ET | Source: iBio, Inc.

iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market

NEWARK, DE--(Marketwired - Aug 14, 2014) - iBio, Inc. (NYSE MKT: IBIO), and Kanematsu Chemicals Corporation, part of Kanematsu Corporation (TSE: 8020), have entered into a collaboration agreement...
July 30, 2014 08:31 ET | Source: iBio, Inc.

iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board

NEWARK, DE--(Marketwired - Jul 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed J....
July 21, 2014 08:31 ET | Source: iBio, Inc.

iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board

NEWARK, DE--(Marketwired - Jul 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Richard...
July 16, 2014 08:31 ET | Source: iBio, Inc.

iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board

NEWARK, DE--(Marketwired - Jul 16, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Timothy...
June 17, 2014 08:31 ET | Source: iBio, Inc.

iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer

NEWARK, DE--(Marketwired - Jun 17, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its...
June 10, 2014 08:31 ET | Source: iBio, Inc.

iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis

NEWARK, DE--(Marketwired - Jun 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue by...
June 05, 2014 08:31 ET | Source: iBio, Inc.

iBio European Patent on iBioModulator Technology Emerges From Opposition Period

NEWARK, DE--(Marketwired - Jun 5, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has surpassed the opposition...
April 24, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology

NEWARK, DE--(Marketwired - Apr 24, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance...
March 27, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives Patent Allowances for Pandemic Influenza Therapeutics

NEWARK, DE--(Marketwired - Mar 27, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of two U.S....
March 04, 2014 08:31 ET | Source: iBio, Inc.

iBio to Present at the 26th Annual ROTH Conference on March 10, 2014

NEWARK, DE--(Marketwired - Mar 4, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has been invited to present at the...